Mundipharma Acquires 'Smart' Chemo Drug From CellAct

 
• By Lucie Ellis-Taitt

Mundipharma has acquired a next-generation chemotherapy agent from German biotech CellAct to further expand its oncology portfolio.

Evolution of lighting
Mundipharma acquires 'smart' chemo agent targeting underserved cancer population • Source: Shutterstock

More from Deals

More from Business